27578508|t|Evaluation of the VIDAS Anti-HCV Assay for Detection of Hepatitis C Virus Infection
27578508|a|Anti-hepatitis C virus antibody (anti-HCV) assays are recommended for screening HCV -infected persons. The VIDAS Anti-HCV Assay (bioMÃ©rieux, France), based on the enzyme-linked fluorescence test principle, was recently introduced in Korea. We evaluated the clinical performance of the VIDAS assay. One hundred HCV-positive and 1,002 HCV-negative blood samples confirmed by Architect anti-HCV (Abbott Laboratories, USA) and COBAS TaqMan HCV real-time PCR (Roche Diagnostics, USA) or the Procleix Ultrio Plus Assay (Gen-Probe Incorporated, USA) were obtained from the Human Serum Bank (HSB) and tested by VIDAS. In case of discrepant results, we conducted a recombinant immunoblot assay (RIBA). The agreement rates for known HCV-positive and HCV-negative samples between the VIDAS assay and the HSB testing were 100% (95% confidence interval [CI]: 96.4-100%) and 99.5% (95% CI: 98.8-99.8%), respectively. One of the five discrepant samples was positive for Core 2+ and NS3-2 2+ reactivity, two samples were negative, and the other two were indeterminate regarding NS4 2+ reactivity in RIBA. We observed a significant but weak positive correlation between the titers of VIDAS and Architect assays (r=0.315, P<0.001). The VIDAS anti-HCV assay, developed on the VIDAS automated immunoassay platform based on the ready-to-use, single-sample test concept may be useful in small-to-medium-sized laboratories. It showed good agreement with Architect anti-HCV and COBAS PCR assays and is therefore useful for detection of HCV infection. Weakly test-positive (ambiguous) samples require additional testing by another anti-HCV, RIBA, or HCV RNA assay.
27578508	0	10	Evaluation	T058	UMLS:C0220825
27578508	18	38	VIDAS Anti-HCV Assay	T058	UMLS:C0005507
27578508	43	52	Detection	T058	UMLS:C1511790
27578508	56	83	Hepatitis C Virus Infection	T038	UMLS:C4288963
27578508	84	115	Anti-hepatitis C virus antibody	T103	UMLS:C0166049
27578508	117	125	anti-HCV	T103	UMLS:C0166049
27578508	127	133	assays	T058	UMLS:C0005507
27578508	154	163	screening	T058	UMLS:C1710032
27578508	164	167	HCV	T005	UMLS:C0220847
27578508	164	185	HCV -infected persons	T098	UMLS:C0027361
27578508	191	211	VIDAS Anti-HCV Assay	T058	UMLS:C0005507
27578508	225	231	France	T082	UMLS:C0016674
27578508	247	278	enzyme-linked fluorescence test	T058	UMLS:C0022885
27578508	317	322	Korea	T082	UMLS:C0022771
27578508	369	380	VIDAS assay	T058	UMLS:C0005507
27578508	394	406	HCV-positive	T033	UMLS:C1112419
27578508	417	429	HCV-negative	T033	UMLS:C1619717
27578508	430	443	blood samples	T031	UMLS:C0178913
27578508	457	475	Architect anti-HCV	T058	UMLS:C0005507
27578508	498	501	USA	T082	UMLS:C0041703
27578508	507	537	COBAS TaqMan HCV real-time PCR	T062	UMLS:C1709846
27578508	539	556	Roche Diagnostics	T092	UMLS:C3828314
27578508	558	561	USA	T082	UMLS:C0041703
27578508	570	596	Procleix Ultrio Plus Assay	T058	UMLS:C0005507
27578508	622	625	USA	T082	UMLS:C0041703
27578508	705	723	discrepant results	T033	UMLS:C1290905
27578508	740	768	recombinant immunoblot assay	T058	UMLS:C2987205
27578508	770	774	RIBA	T058	UMLS:C2987205
27578508	807	819	HCV-positive	T033	UMLS:C1112419
27578508	824	836	HCV-negative	T033	UMLS:C1619717
27578508	837	844	samples	T031	UMLS:C0178913
27578508	857	868	VIDAS assay	T058	UMLS:C0005507
27578508	1003	1013	discrepant	T033	UMLS:C1290905
27578508	1014	1021	samples	T031	UMLS:C0178913
27578508	1026	1034	positive	T033	UMLS:C1446409
27578508	1039	1046	Core 2+	T103	UMLS:C0019166
27578508	1051	1059	NS3-2 2+	T103	UMLS:C0021054
27578508	1076	1083	samples	T031	UMLS:C0178913
27578508	1089	1097	negative	T033	UMLS:C0205160
27578508	1146	1152	NS4 2+	T103	UMLS:C0021054
27578508	1167	1171	RIBA	T058	UMLS:C2987205
27578508	1261	1277	Architect assays	T058	UMLS:C0005507
27578508	1302	1322	VIDAS anti-HCV assay	T058	UMLS:C0005507
27578508	1347	1377	automated immunoassay platform	T058	UMLS:C0020980
27578508	1471	1483	laboratories	T092	UMLS:C0022877
27578508	1515	1533	Architect anti-HCV	T058	UMLS:C0005507
27578508	1538	1554	COBAS PCR assays	T062	UMLS:C1709846
27578508	1596	1609	HCV infection	T038	UMLS:C4288963
27578508	1611	1643	Weakly test-positive (ambiguous)	T033	UMLS:C0456984
27578508	1644	1651	samples	T031	UMLS:C0178913
27578508	1690	1698	anti-HCV	T103	UMLS:C0166049
27578508	1700	1704	RIBA	T058	UMLS:C2987205
27578508	1709	1722	HCV RNA assay	T058	UMLS:C1272251